Facebook
Twitter
LinkedIn
ForwardExploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
Effectively and safely lowering LDL-C is essential to prevent and reduce the risk of recurrent ASCVD events.
Understanding the Role of Lp(a) as a CV Risk Marker to Therapeutic Target in the Prevention of ASCVD
Residual ASCVD risk may be present even after the optimization of LDL-C levels and increasing evidence has suggested that elevated Lp(a) is an emerging CVD risk factor that has been shown to be a causal CVD risk factor in epidemiological and genetic studies, as well as enha
Ace the Case Challenge Series: Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk
Effectively managing high cholesterol level and safely lowering LDL-C is crucial for preventing and reducing the risk of adverse cardiovascular events. However, achieving LDL-C goals remains suboptimal, particularly in high-risk and very high-risk patients.
Ace the Case Challenge Series: The Intersection of MASH and Cardiometabolic Risk
This Ace the Case Series is designed to be quick and offer high-level takeaways and pearls.Case #1: A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound
The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes
This activity consists of a recorded presentation at the 2024 Women's Health and Wellness Masterclass, held in April 2024 in Dana Point, CA. The session, "The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes" was presented by Debbie Cohen, MD
The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
This activity consists of a recorded presentation at the 2024 Women's Health and Wellness Masterclass, held in April 2024 in Dana Point, CA. The symposium, "The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes" was pr
Podcast - Ironing Out the Data: Iron Deficiency in Heart Failure
CardioNerds Cofounder Dr. Amit Goyal, Chair of the CardioNerds Heart Failure Committee Dr. Jenna Skowronski, and Episode FIT Lead Dr. Shazli Khan discuss iron deficiency and its impact on heart failure with Dr.
Optimizing the Recognition and Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes: What Primary Care Clinicians Need to Know
Welcome to our micro-module webcast on the challenges of managing chronic kidney disease (CKD) and diabetes. After diagnosis, slowing CKD progression in type 2 diabetes (T2D) continues to pose a major challenge.
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
Dr. Ronald M. Krauss, MD, Professor of Medicine at UCSF and Adjunct Professor of Nutritional Sciences at UC Berkeley, and Nina Teicholz, PhD, author and science journalist, co-organized this course on Dietary Approaches to Reversing Type 2 Diabetes.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 4.00 Participation
Cost $0.00
At the Forefront of Care for Patients with Worsening Heart Failure: New and Emerging Treatment Options
Welcome to our webcast on worsening heart failure. Heart failure remains one of the most challenging conditions to manage, with worsening heart failure being a critical area where suboptimal outcomes persist.